Magnetic resonance imaging of focal splenic and hepatic lesions in the dog

Journal of Veterinary Internal Medicine

Volumn 18, Issue 3, 2004, Pages 330-338

  Clifford, Craig A ^a,c   Pretorius, E Scott ^b   Weisse, Chick ^a   Sorenmo, Karin U ^a   Drobatz, Kenneth J ^a   Siegelman, Evan S ^b   Solomon, Jeffrey A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c RED BANK VETERINARY HOSPITAL   (United States)

Author keywords

Abdominal imaging; Hemangiosarcoma; Hepatocellular carcinoma; Nodular hyperplasia

Indexed keywords

ABDOMINAL RADIOGRAPHY; ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; LIVER CELL CARCINOMA; LIVER INJURY; MALIGNANT NEOPLASTIC DISEASE; NODULAR HYPERPLASIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPLEEN INJURY; TUMOR DIAGNOSIS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DOG DISEASES; DOGS; HEMANGIOSARCOMA; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPLENIC NEOPLASMS;

ANIMALIA; CANIS FAMILIARIS;

EID: 2942561058     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<330:MRIOFS>2.0.CO;2     Document Type: Article

References (65)

1. Prause LC, Twedt DC. Hepatic nodular hyperplasia. In: Bonagura JD, ed. Kirk's Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:675-676.
2. Johnson SE. Chronic hepatic disorders. In: Ettinger SJ. Textbook of Veterinary Internal Medicine. Philadelphia, PA: WB Saunders; 2000:1298-1323.
3. Thamm DH. Hepatobiliary tumors. In: Withrow SJ, Mac Ewen EG, eds. Small Animal Clinical Oncology. Philadelphia, PA: WB Saunders; 2001:327-334.
4. Ramos-Vara JA, Miller MA, Johnson GC. Immunohistochemical characterization of hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7. Vet Pathol 2001;38:636-643.
5. Spangler WL, Culbertson MR. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 1992;200:829-834.
6. Spangler WL, Kass PH. Pathologic and prognostic characteristics of splenomegaly in dogs due to fibrohistiocytic nodules: 98 cases. Vet Pathol 1998;35:488-498.
7. Day MJ, Lucke VM, Pearson H. A review of pathological diagnoses made from 87 canine splenic biopsies. J Small Anim Pract 1995;36:426-433.
8. Prymak C, McKee LJ, Goldschmidt MHS, et al. Epidemiologic, clinical pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs. J Am Vet Med Assoc 1988;193:706-712.
9. Cuccovillo A, Lamb CR. Cellular features of sonographic target lesions of the liver and spleen in 21 dogs and a cat. Vet Radiol Ultrasound 2002;43:275-278.
10. De Rycke LM, van Bree HJ, Simoens PJ. Ultrasound-guided tissue-core biopsy of liver, spleen and kidney in normal dogs. Vet Radiol Ultrasound 1999;40:294-299.
11. Lamb CR. Abdominal ultrasonography in small animals: Examination of the liver, spleen and pancreas. J Small Anim Pract 1990;31:5-14.
12. Wrigley RH. Ultrasonography of the spleen. Life-threatening splenic disorders. Probl Vet Med 1991;3:574-581.
13. Martin D, Semelka M, Semelka R. Imaging of benign and malignant focal liver lesions. MRI Clin North Am 2001;9:785-802.
14. Semelka RC, Cance WG, Marcos HB, et al. Liver metastases: Comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86-91.
15. Semelka RC, Martin DR, Balci C, et al. Focal liver lesions. Comparison of dual phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401.
16. Semelka RC, Schlund JF, Molina PL, et al. Malignant liver lesions: Comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 1996;6:39-43.
17. Semelka RC, Hussain SM, Marcos HB, et al. Perilesional enhancement of hepatic metastases: Correlation between MR imaging and histopathologic findings - Initial observations. Radiology 2000;215:84-89.
18. Motohara T, Semelka RC, Nagase L. MR imaging of benign hepatic tumors. MRI Clin North Am 2002;10:1-14.
19. Pedro MS, Semelka RC, Nagase L. MR imaging of hepatic metastases. MRI Clin North Am 2002;10:15-30.
20. Hussain SH, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. MRI Clin North Am 2002;10:31-52.
21. Braga L, Semelka RC, Pedro MS, et al. Post-treatment malignant liver lesions: MR imaging. MRI Clin North Am 2002;10:53-74.
22. Low RN. MR imaging of the liver using gadolinium chelates. MRI Clin North Am 2001;9:717-744.
23. Awaya H, Ito K, Honjo K, et al. Differential diagnosis of hepatic tumors with delayed enhancement at Gadolinium enhanced MRI: A pictorial essay. Clin Imaging 1998;22:180-187.
24. Larson RE, Semelka RC, Bagley AS, et al. Hypervascular malignant liver lesions: Comparison of various MR imaging pulse sequences and dynamic CT. Radiology 1994;192:393-399.
25. Mitchell DG. Liver I: Currently available gadolinium chelates. Magn Reson Imaging Clin North Am 1996;4:37-51.
26. Murakami T, Hironobu N, Tsuda K, et al. Contrast enhanced MR imaging of cholangiocarcinoma: Pathologic correlation study. J Magn Reson Imaging 1995;5:165-170.
27. Urrutia M, Mergo PJ, Ros LH, et al. Cystic masses of the spleen: Radiologic-pathologic correlation. Radiographics 1996;16:107-129.
28. Ramani M, Reinhold C, Semelka RC, et al. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology 1997;202:166-172.
29. Paterson A, Frush DP, Donnelly LF, et al. Primary angiosarcoma of the spleen - CT, MR, and sonographic characteristics: Report of two cases. Abdom Imaging 2000;25:283-285.
30. Kinoshita T, Ishii K, Yajima Y, et al. Splenic hemangiosarcoma with massive calcification., Abdom Imaging 1999;24:185-187.
31. Gopal MS, Jeffery ND. Magnetic resonance imaging in the diagnosis and treatment of canine spinal cord injury. JSAP 2001;42:29-31.
32. Mellema LM, Koblik PD, Kortz GD, et al. Reversible magnetic resonance imaging abnormalities in dogs following seizures. Vet Radiol Ultrasound 1999;40:588-595.
33. Kraft SL, Gavin PR. Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging. J Vet Intern Med 1997;11:218-225.
34. Ramirez O, Thrall DE. A review of imaging techniques for cauda equina syndrome. Vet Radiol Ultrasound 1998;27:263-270.
35. Graham JP, Roberts GD, Newell SM. Dynamic magnetic resonance imaging of the normal pituitary gland. Vet Radiol Ultrasound 2000;41:35-40.
36. Wallack ST, Wisner ER, Werner JA, et al. Accuracy of magnetic resonance imaging for estimating intramedullary osteosarcoma extent in pre-operative planning for limb-salvage procedures. Vet Radiol Ultrasound 2002;43:432-441.
37. Llabres-Diaz FJ, Dennis R. Magnetic resonance imaging of the presumed normal canine adrenal glands. Vet Radiol Ultrasound 2003;44:5-19.
38. Banfield CM, Morrison WB. Magnetic resonance arthrography of the canine stifle joint: Technique and applications in eleven military dogs. Vet Radiol Ultrasound 2000;41:200-213.
39. Baird DK, Hathcock JT, Rumph PF, et al. Low-field magnetic resonance imaging of the canine stifle joint: Normal anatomy. Vet Radiol Ultrasound 1998;39:87-97.
40. Muleya JS, Taura Y, Nakaichi M, et al. Appearance of canine abdominal tumors with magnetic resonance imaging using a low field permanent magnet. Vet Radiol Ultrasound 1997;38:444-447.
41. Wallis F, Gilbert FJ. Magnetic resonance imaging in oncology: An overview. J R Coll Surg Edinburgh 1999;44:117-125.
42. Paley MR, Ros PR. MR imaging of the liver - A practical approach. Magn Reson Imaging Clin North Am 1997;5:415-429.
43. Carlos RC, Kim HM, Hussain HK, et al. Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis AJR. Am J Roentgenol 2003;180:893-900.
44. Kamel IR, Bluemke DA. Imaging evaluation of hepatocellular carcinoma. J Vasc Intervent Radiol 2002;13:S173-S184.
45. Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002;12:2258-2272.
46. Levy AD. Malignant liver tumors. Clin Liver Dis 2002;6:147-164.
47. Bartolozzi C, Cioni D, Donati F, et al. Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 2001;11:1374-1388.
48. Harisinghani MG, Hahn PF. Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterol Clin North Am 2002;31:759-776.
49. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation. Radiology 2001;219:445-454.
50. Kanematsu M, Hoshi H, Murakami T, et al. Fat-suppressed T2-weighted MR imaging of hepatocellular carcinoma and metastases: Comparison of conventional spin-echo, fast spin-echo, and echoplanar pulse sequences. J Magn Reson Imaging 1999;10:25-32.
51. Van Beers BE, Materne R, Lacrosse M, et al. MR imaging of hypervascular liver tumors: Timing optimization during the arterial phase. J Magn Reson Imaging 1999;9:562-567.
52. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology. Eur Radiol 1999;9:62-67.
53. Matsuo M, Kanematsu M, Itoh K, et al. Detection of malignant hepatic tumors: Comparison of gadolinium-and ferumoxide-enhanced MR imaging. Am J Roentgenol 2001;177:637-643.
54. Tanimoto A, Yuasa Y, Jinzaki M, et al. Routine MR imaging protocol with breath-hold fast scans: Diagnostic efficacy for focal liver lesions. Radiat Med 2002;20:169-179.
55. Imam K, Bluemke DA. MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin North Am 2000;8:741-756.
56. Lewis KH, Chezmar JL. Hepatic metastases. Magn Reson Imaging Clin North Am 1997;5:319-330.
57. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology. 1999;30:889-893.
58. Clouet M, Boulay I, Boudiaf M, et al. Imaging features of nodular regenerative hyperplasia of the liver mimicking hepatic metastases. Abdom Imaging 1999;24:258-261.
59. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327-336.
60. Brancatelli G, Federle MP, Grazioli L, et al. Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: Radiologic-pathologic and clinical correlation. Radiographics 2002;22:847-862.
61. Seneterre E, Tauorel P, Bouvier Y, et al. Detection of hepatic metastases: Ferumoxide-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996;200:785-792.
62. Vassiliades VG, Foley WD, Alarcon J, et al. Hepatic metastases: CT versus MR imaging at 1.5 T. Gastrointest Radiol 1991;16:159-163.
63. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-1200.
64. de Beck BO, Luypaert R, Dujardin M, et al. Benign liver lesions: Differentiation by magnetic resonance. Eur J Radiol 1999;32:52-60.
65. Yamashita Y, Fan ZM, Yamamoto H, et al. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: Correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83-90.